These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

494 related items for PubMed ID: 30267281

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
    Hanauer SB, Sandborn WJ, Lichtenstein GR.
    Gastroenterology; 2019 Jan; 156(1):36-42. PubMed ID: 30195449
    [Abstract] [Full Text] [Related]

  • 3. How should immunomodulators be optimized when used as combination therapy with anti-tumor necrosis factor agents in the management of inflammatory bowel disease?
    Ward MG, Irving PM, Sparrow MP.
    World J Gastroenterol; 2015 Oct 28; 21(40):11331-42. PubMed ID: 26525434
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun 28; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 7. Methotrexate in inflammatory bowel disease: A primer for gastroenterologists.
    AlAmeel T, Al Sulais E, Raine T.
    Saudi J Gastroenterol; 2022 Jun 28; 28(4):250-260. PubMed ID: 35042318
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. When to Start Immunomodulators in Inflammatory Bowel Disease?
    Sharara AI.
    Dig Dis; 2016 Jun 28; 34(1-2):125-31. PubMed ID: 26982809
    [Abstract] [Full Text] [Related]

  • 11. Is there room for immunomodulators in ulcerative colitis?
    Chhibba T, Ma C.
    Expert Opin Biol Ther; 2020 Apr 28; 20(4):379-390. PubMed ID: 31874578
    [Abstract] [Full Text] [Related]

  • 12. Systematic Review: Cost-effective Strategies of Optimizing Anti-tumor Necrosis and Immunomodulators in Inflammatory Bowel Disease.
    Vasudevan A, Gibson PR, Van Langenberg DR.
    Inflamm Bowel Dis; 2019 Aug 20; 25(9):1462-1473. PubMed ID: 30689858
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Use of thiopurines in inflammatory bowel disease.
    Frei P, Biedermann L, Nielsen OH, Rogler G.
    World J Gastroenterol; 2013 Feb 21; 19(7):1040-8. PubMed ID: 23467510
    [Abstract] [Full Text] [Related]

  • 15. Drug resistance in inflammatory bowel diseases.
    Moreau J, Mas E.
    Curr Opin Pharmacol; 2015 Dec 21; 25():56-61. PubMed ID: 26645664
    [Abstract] [Full Text] [Related]

  • 16. Aminosalicylates, thiopurines and methotrexate in inflammatory bowel disease: Is it possible to discontinue the treatment?
    Sedano Muñoz R, Quera Pino R, Ibáñez Lazo P, Figueroa Corona C, Flores Pérez L.
    Gastroenterol Hepatol; 2019 May 21; 42(5):339-347. PubMed ID: 30954317
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Therapeutic Drug Monitoring in Pediatric Inflammatory Bowel Disease.
    Carman N, Mack DR, Benchimol EI.
    Curr Gastroenterol Rep; 2018 Apr 05; 20(5):18. PubMed ID: 29623442
    [Abstract] [Full Text] [Related]

  • 20. Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.
    Absah I, Faubion WA.
    Inflamm Bowel Dis; 2012 Aug 05; 18(8):1488-92. PubMed ID: 21882301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.